Globe Editorial
EACH YEAR, about 3,900 women die of cervical cancer in the United States. In time, that toll should decline significantly with the approval of the first vaccine against the disease on June 8. But the greatest potential benefit of Merck's Gardasil vaccine will come only if parents, doctors, policymakers, public health professionals, and school officials work together to ensure that ... (Full article: 454 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
